Starting with Zepbound: Dosage and Application Zepbound is a once-weekly subcutaneous injection, commonly administered in the thigh, abdomen, or upper arm
Maintenance dosing: After reaching target doses through escalation, maintenance protocols continue at stable levels
It is essential to follow the treatment plan and duration recommended by your provider
Semaglutide, the active ingredient of Wegovy, is a GLP-1 receptor agonist that helps reduce appetite and regulates blood sugar levels
This decision is highly personal and should be made in partnership with a qualified bariatric care team that considers: Medical history Insurance eligibility Weight loss goals Long-term health outcomes What Patients in California Should Consider Next If you are currently usingor consideringGLP-1 medications and are concerned about insurance coverage, cost, or long-term sustainability, it may be time to explore all evidence-based weight loss options
You adjust the bacteriostatic water volume to hit your target concentration